| Krystexxa |
125293 |
001 |
351(a) |
pegloticase |
Injection |
Intravenous |
8MG/ML |
Single-Dose Vial |
2010/09/14
|
Horizon Therapeutics Ireland DAC |
Rx |
Licensed |
N/A |
N/A |
| Novoseven, Novoseven Rt |
103665 |
007 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
8.0MG |
Single-Dose Vial |
2010/08/06
|
Novo Nordisk Inc. |
Rx |
Licensed |
|
N/A |
| Xyntha, Xyntha Solofuse |
125264 |
009 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free |
For Injection |
Intravenous |
3000IU |
Pre-Filled Syringe |
2010/08/06
|
Wyeth Pharmaceuticals LLC |
Rx |
Licensed |
|
N/A |
| Xeomin |
125360 |
001 |
351(a) |
incobotulinumtoxinA |
For Injection |
Intramuscular, Intraglandular |
50UNITS |
Single-Dose Vial |
2010/07/30
|
Merz Pharmaceuticals GmbH c/o Merz Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Xeomin |
125360 |
002 |
351(a) |
incobotulinumtoxinA |
For Injection |
Intramuscular, Intraglandular |
100UNITS |
Single-Dose Vial |
2010/07/30
|
Merz Pharmaceuticals GmbH c/o Merz Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
006 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5G/50ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
007 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10G/100ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
008 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
20G/200ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Glassia |
125325 |
001 |
351(a) |
Alpha-1-Proteinase Inhibitor (Human) |
Injection |
Intravenous |
1G |
Single-Dose Vial |
2010/07/01
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Prolia |
125320 |
001 |
351(a) |
denosumab |
Injection |
Subcutaneous |
60MG/ML |
Pre-Filled Syringe |
2010/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Prolia |
125320 |
002 |
351(a) |
denosumab |
Injection |
Subcutaneous |
60MG/ML |
Single-Dose Vial |
2010/06/01
|
Amgen Inc. |
Disc |
Licensed |
N/A |
N/A |
| Lumizyme |
125291 |
001 |
351(a) |
alglucosidase alfa |
For Injection |
Intravenous |
50MG |
Single-Dose Vial |
2010/05/24
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |
| Provenge |
125197 |
001 |
351(a) |
sipuleucel-T |
Injection |
Intravenous |
50 M CD54 + ACTIVATED CELLS/250 ML |
Bag |
2010/04/29
|
Dendreon Pharmaceuticals LLC |
Disc |
Licensed |
|
N/A |
| Pancreaze |
022523 |
001 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
4,200USP UNITS; 14,200USP UNITS; 24,600USP UNITS |
|
2010/04/12
|
VIVUS LLC |
Rx |
Licensed |
N/A |
N/A |
| Pancreaze |
022523 |
002 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
10,500USP UNITS; 35,500USP UNITS; 61,500USP UNITS |
|
2010/04/12
|
VIVUS LLC |
Rx |
Licensed |
N/A |
N/A |
| Pancreaze |
022523 |
003 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
16,800USP UNITS; 56,800USP UNITS; 98,400USP UNITS |
|
2010/04/12
|
VIVUS LLC |
Rx |
Licensed |
N/A |
N/A |
| Pancreaze |
022523 |
004 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
21,000USP UNITS; 54,700USP UNITS; 83,900USP UNITS |
|
2010/04/12
|
VIVUS LLC |
Rx |
Licensed |
N/A |
N/A |
| Tachosil |
125351 |
001 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
4.8 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN |
Tray & Lid |
2010/04/05
|
Corza Medical GmbH |
Rx |
Licensed |
|
N/A |
| Tachosil |
125351 |
002 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
9.5 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN |
Tray & Lid |
2010/04/05
|
Corza Medical GmbH |
Rx |
Licensed |
|
N/A |
| Tachosil |
125351 |
003 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
3.0 CM X 2.5 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN |
Tray & Lid |
2010/04/05
|
Corza Medical GmbH |
Disc |
Licensed |
|
N/A |